6 0 1 0 1 B-lower_bound
months 2 8 2 8 I-lower_bound
to 9 11 9 11 O
= 12 13 12 13 O
< 13 14 13 14 O
45 15 17 15 17 B-upper_bound
years 18 23 18 23 I-upper_bound

6 0 1 24 25 B-lower_bound
months 2 8 26 32 I-lower_bound
to 9 11 33 35 O
= 12 13 36 37 O
< 13 14 37 38 O
65 15 17 39 41 B-upper_bound
years 18 23 42 47 I-upper_bound

Acute 0 5 48 53 B-cancer
lymphoblastic 6 19 54 67 I-cancer
leukemia 20 28 68 76 I-cancer
, 28 29 76 77 O
including 30 39 78 87 O
biphenotypic 40 52 88 100 B-cancer
acute 53 58 101 106 I-cancer
leukemia 59 67 107 115 I-cancer
or 68 70 116 118 O
mixed 71 76 119 124 B-cancer
- 76 77 124 125 I-cancer
lineage 77 84 125 132 I-cancer
leukemia 85 93 133 141 I-cancer

Acute 0 5 142 147 B-cancer
myeloid 6 13 148 155 I-cancer
leukemia 14 22 156 164 I-cancer
, 22 23 164 165 O
including 24 33 166 175 O
biphenotypic 34 46 176 188 B-cancer
acute 47 52 189 194 I-cancer
leukemia 53 61 195 203 I-cancer
or 62 64 204 206 O
mixed 65 70 207 212 B-cancer
- 70 71 212 213 I-cancer
lineage 71 78 213 220 I-cancer
leukemia 79 87 221 229 I-cancer

Advanced 0 8 230 238 O
myelofibrosis 9 22 239 252 B-cancer

All 0 3 253 256 O
patients 4 12 257 265 O
must 13 17 266 270 O
be 18 20 271 273 O
in 21 23 274 276 O
CR 24 26 277 279 O
as 27 29 280 282 O
defined 30 37 283 290 O
by 38 40 291 293 O
< 41 42 294 295 O
5 43 44 296 297 B-upper_bound
% 44 45 297 298 I-upper_bound
blasts 46 52 299 305 B-clinical_variable
by 53 55 306 308 O
morphology 56 66 309 319 O

All 0 3 320 323 O
patients 4 12 324 332 O
must 13 17 333 337 O
be 18 20 338 340 O
in 21 23 341 343 O
complete 24 32 344 352 O
remission 33 42 353 362 O
( 43 44 363 364 O
CR 44 46 364 366 O
) 46 47 366 367 O
as 48 50 368 370 O
defined 51 58 371 378 O
by 59 61 379 381 O
hematologic 62 73 382 393 O
recovery 74 82 394 402 O
and 83 86 403 406 O
< 87 88 407 408 O
5 89 90 409 410 B-upper_bound
% 90 91 410 411 I-upper_bound
blasts 92 98 412 418 B-clinical_variable
by 99 101 419 421 O
morphology 102 112 422 432 B-treatment
/ 112 113 432 433 O
flow 113 117 433 437 B-treatment
cytometry 118 127 438 447 I-treatment
in 128 130 448 450 O
a 131 132 451 452 O
representative 133 147 453 467 O
bone 148 152 468 472 O
marrow 153 159 473 479 O
sample 160 166 480 486 O
with 167 171 487 491 O
cellularity 172 183 492 503 B-clinical_variable
> 184 185 504 505 O
= 185 186 505 506 O
15 187 189 507 509 B-lower_bound
% 189 190 509 510 I-lower_bound
for 191 194 511 514 O
age 195 198 515 518 B-age

Any 0 3 519 522 O
prior 4 9 523 528 O
myeloablative 10 23 529 542 B-treatment
transplant 24 34 543 553 I-treatment
within 35 41 554 560 O
the 42 45 561 564 O
last 46 50 565 569 O
6 51 52 570 571 B-upper_bound
months 53 59 572 578 I-upper_bound

Chemotherapy 0 12 579 591 B-treatment
refractory 13 23 592 602 B-cancer
large 24 29 603 608 I-cancer
cell 30 34 609 613 I-cancer
and 35 38 614 617 O
high 39 43 618 622 B-cancer
grade 44 49 623 628 I-cancer
NHL 50 53 629 632 I-cancer
( 54 55 633 634 O
i.e. 55 59 634 638 O
, 59 60 638 639 O
progressive 61 72 640 651 O
disease 73 80 652 659 O
after 81 86 660 665 O
> 87 88 666 667 O
2 89 90 668 669 B-lower_bound
salvage 91 98 670 677 B-treatment
regimens 99 107 678 686 I-treatment
) 107 108 686 687 O

Chronic 0 7 688 695 B-cancer
lymphocytic 8 19 696 707 I-cancer
leukemia 20 28 708 716 I-cancer
/small 29 35 717 723 O
lymphocytic 36 47 724 735 I-cancer
lymphoma 48 56 736 744 I-cancer
( 57 58 745 746 O
CLL 58 61 746 749 B-cancer
/ 61 62 749 750 O
SLL 62 65 750 753 B-cancer
) 65 66 753 754 O
, 66 67 754 755 O
marginal 68 76 756 764 B-cancer
zone 77 81 765 769 I-cancer
B 82 83 770 771 I-cancer
- 83 84 771 772 I-cancer
cell 84 88 772 776 I-cancer
lymphoma 89 97 777 785 I-cancer
, 97 98 785 786 O
lymphoplasmacytic 99 116 787 804 B-cancer
lymphoma 117 125 805 813 I-cancer
or 126 128 814 816 O
follicular 129 139 817 827 B-cancer
lymphoma 140 148 828 836 I-cancer
that 149 153 837 841 O
have 154 158 842 846 O
progressed 159 169 847 857 O
after 170 175 858 863 O
at 176 178 864 866 O
least 179 184 867 872 O
two 185 188 873 876 B-lower_bound
different 189 198 877 886 O
prior 199 204 887 892 B-treatment
therapies 205 214 893 902 I-treatment

Chronic 0 7 903 910 B-cancer
myelogenous 8 19 911 922 I-cancer
leukemia 20 28 923 931 I-cancer
excluding 29 38 932 941 O
refractory 39 49 942 952 O
blast 50 55 953 958 O
crisis 56 62 959 965 O

Conditioning 0 12 966 978 O
regimen 13 20 979 986 O
selection 21 30 987 996 O
should 31 37 997 1003 O
be 38 40 1004 1006 O
based 41 46 1007 1012 O
on 47 49 1013 1015 O
the 50 53 1016 1019 O
underlying 54 64 1020 1030 O
disease 65 72 1031 1038 O
, 72 73 1038 1039 O
presence 74 82 1040 1048 O
of 83 85 1049 1051 O
minimum 86 93 1052 1059 B-cancer
residual 94 102 1060 1068 I-cancer
disease 103 110 1069 1076 I-cancer
( 111 112 1077 1078 I-cancer
MRD 112 115 1078 1081 I-cancer
) 115 116 1081 1082 I-cancer
, 116 117 1082 1083 O
age 118 121 1084 1087 B-age
, 121 122 1087 1088 O
co 123 125 1089 1091 O
- 125 126 1091 1092 O
morbidities 126 137 1092 1103 O
, 137 138 1103 1104 O
attending 139 148 1105 1114 O
physician 149 158 1115 1124 O
, 158 159 1124 1125 O
and 160 163 1126 1129 O
site 164 168 1130 1134 O
preference 169 179 1135 1145 O

Creatinine 0 10 1146 1156 B-clinical_variable
< 11 12 1157 1158 O
2.0 13 16 1159 1162 B-upper_bound
mg 17 19 1163 1165 I-upper_bound
/ 19 20 1165 1166 I-upper_bound
dL 20 22 1166 1168 I-upper_bound
( 23 24 1169 1170 O
for 24 27 1170 1173 O
adults 28 34 1174 1180 O
) 34 35 1180 1181 O

Diffusion 0 9 1182 1191 O
capacity 10 18 1192 1200 O
for 19 22 1201 1204 O
carbon 23 29 1205 1211 B-clinical_variable
monoxide 30 38 1212 1220 I-clinical_variable
corrected 39 48 1221 1230 I-clinical_variable
( 49 50 1231 1232 I-clinical_variable
DLCOcorr 50 58 1232 1240 I-clinical_variable
) 58 59 1240 1241 I-clinical_variable
> 60 61 1242 1243 O
50 62 64 1244 1246 B-lower_bound
% 64 65 1246 1247 I-lower_bound
normal 66 72 1248 1254 O
or 73 75 1255 1257 O
a 76 77 1258 1259 O
pediatric 78 87 1260 1269 O
patient 88 95 1270 1277 O
who 96 99 1278 1281 O
is 100 102 1282 1284 O
unable 103 109 1285 1291 O
to 110 112 1292 1294 O
perform 113 120 1295 1302 O
pulmonary 121 130 1303 1312 B-treatment
function 131 139 1313 1321 I-treatment
tests 140 145 1322 1327 I-treatment
( 146 147 1328 1329 I-treatment
PFTs 147 151 1329 1333 I-treatment
) 151 152 1333 1334 I-treatment
but 153 156 1335 1338 O
has 157 160 1339 1342 O
adequate 161 169 1343 1351 O
pulmonary 170 179 1352 1361 O
function 180 188 1362 1370 O

Eastern 0 7 1371 1378 B-clinical_variable
Cooperative 8 19 1379 1390 I-clinical_variable
Oncology 20 28 1391 1399 I-clinical_variable
Group 29 34 1400 1405 I-clinical_variable
( 35 36 1406 1407 I-clinical_variable
ECOG 36 40 1407 1411 I-clinical_variable
) 40 41 1411 1412 I-clinical_variable
0 42 43 1413 1414 B-lower_bound
- 43 44 1414 1415 O
1 44 45 1415 1416 B-upper_bound
or 46 48 1417 1419 O
Lansky 49 55 1420 1426 B-clinical_variable
( 56 57 1427 1428 O
for 57 60 1428 1431 O
children 61 69 1432 1440 O
) 69 70 1440 1441 O
> 71 72 1442 1443 O
= 72 73 1443 1444 O
50 74 76 1445 1447 B-lower_bound
% 76 77 1447 1448 I-lower_bound

Eligible 0 8 1449 1457 O
after 9 14 1458 1463 O
initial 15 22 1464 1471 O
therapy 23 30 1472 1479 B-clinical_variable
in 31 33 1480 1482 I-clinical_variable
> 34 35 1483 1484 O
= 35 36 1484 1485 O
CR1 37 40 1486 1489 B-lower_bound
or 41 43 1490 1492 O
> 44 45 1493 1494 O
= 45 46 1494 1495 O
PR1 47 50 1496 1499 B-lower_bound

High 0 4 1500 1504 O
- 4 5 1504 1505 O
dose 5 9 1505 1509 O
TBI 10 13 1510 1513 B-treatment
regimen 14 21 1514 1521 I-treatment

History 0 7 1522 1529 O
of 8 10 1530 1532 O
human 11 16 1533 1538 B-chronic_disease
immunodeficiency 17 33 1539 1555 I-chronic_disease
virus 34 39 1556 1561 I-chronic_disease
( 40 41 1562 1563 I-chronic_disease
HIV 41 44 1563 1566 I-chronic_disease
) 44 45 1566 1567 I-chronic_disease
infection 46 55 1568 1577 I-chronic_disease

Karnofsky 0 9 1578 1587 B-clinical_variable
( 10 11 1588 1589 O
for 11 14 1589 1592 O
adults 15 21 1593 1599 O
) 21 22 1599 1600 O
> 23 24 1601 1602 O
= 24 25 1602 1603 O
70 26 28 1604 1606 B-lower_bound
% 28 29 1606 1607 I-lower_bound

Large 0 5 1608 1613 B-clinical_variable
cell 6 10 1614 1618 I-clinical_variable
NHL 11 14 1619 1622 I-clinical_variable
> 15 16 1623 1624 O
CR2/ 17 21 1625 1629 B-lower_bound
> 21 22 1629 1630 O
second 23 29 1631 1637 B-lower_bound
partial 30 37 1638 1645 I-lower_bound
response 38 46 1646 1654 I-lower_bound
( 47 48 1655 1656 I-lower_bound
PR2 48 51 1656 1659 I-lower_bound
) 51 52 1659 1660 I-lower_bound

Left 0 4 1661 1665 B-clinical_variable
ventricular 5 16 1666 1677 I-clinical_variable
ejection 17 25 1678 1686 I-clinical_variable
fraction 26 34 1687 1695 I-clinical_variable
> 35 36 1696 1697 O
45 37 39 1698 1700 B-lower_bound
% 39 40 1700 1701 I-lower_bound
or 41 43 1702 1704 O
shortening 44 54 1705 1715 B-clinical_variable
fraction 55 63 1716 1724 I-clinical_variable
> 64 65 1725 1726 O
26 66 68 1727 1729 B-lower_bound
% 68 69 1729 1730 I-lower_bound

Lymphoblastic 0 13 1731 1744 B-cancer
lymphoma 14 22 1745 1753 I-cancer
, 22 23 1753 1754 O
Burkitt 24 31 1755 1762 B-cancer
's 31 33 1762 1764 I-cancer
lymphoma 34 42 1765 1773 I-cancer
, 42 43 1773 1774 O
and 44 47 1775 1778 O
other 48 53 1779 1784 O
high 54 58 1785 1789 B-cancer
- 58 59 1789 1790 I-cancer
grade 59 64 1790 1795 I-cancer
non 65 68 1796 1799 I-cancer
- 68 69 1799 1800 I-cancer
Hodgkin 69 76 1800 1807 I-cancer
lymphoma 77 85 1808 1816 I-cancer
( 86 87 1817 1818 I-cancer
NHL 87 90 1818 1821 I-cancer
) 90 91 1821 1822 I-cancer
after 92 97 1823 1828 O
initial 98 105 1829 1836 B-treatment
therapy 106 113 1837 1844 I-treatment
if 114 116 1845 1847 O
stage 117 122 1848 1853 B-lower_bound
III 123 126 1854 1857 I-lower_bound
/ 126 127 1857 1858 O
IV 127 129 1858 1860 B-upper_bound
in 130 132 1861 1863 O
first 133 138 1864 1869 O
partial 139 146 1870 1877 O
response 147 155 1878 1886 O
( 156 157 1887 1888 O
PR1 157 160 1888 1891 O
) 160 161 1891 1892 O
or 162 164 1893 1895 O
after 165 170 1896 1901 O
progression 171 182 1902 1913 O
if 183 185 1914 1916 O
stage 186 191 1917 1922 O
I 192 193 1923 1924 O
/ 193 194 1924 1925 O
II 194 196 1925 1927 O
< 197 198 1928 1929 O
1 199 200 1930 1931 B-upper_bound
year 201 205 1932 1936 I-upper_bound

Mantle 0 6 1937 1943 B-cancer
- 6 7 1943 1944 I-cancer
cell 7 11 1944 1948 I-cancer
lymphoma 12 20 1949 1957 I-cancer
, 20 21 1957 1958 O
prolymphocytic 22 36 1959 1973 B-cancer
leukemia 37 45 1974 1982 I-cancer

Middle 0 6 1983 1989 O
- 6 7 1989 1990 O
intensity 7 16 1990 1999 O
TBI 17 20 2000 2003 B-treatment
regimen 21 28 2004 2011 I-treatment

Multiple 0 8 2012 2020 B-cancer
myeloma 9 16 2021 2028 I-cancer
beyond 17 23 2029 2035 O
PR2 24 27 2036 2039 O

Myelodysplasia 0 14 2040 2054 B-cancer
( 15 16 2055 2056 I-cancer
MDS 16 19 2056 2059 I-cancer
) 19 20 2059 2060 I-cancer
International 21 34 2061 2074 B-clinical_variable
Prognostic 35 45 2075 2085 I-clinical_variable
Scoring 46 53 2086 2093 I-clinical_variable
System 54 60 2094 2100 I-clinical_variable
( 61 62 2101 2102 I-clinical_variable
IPSS 62 66 2102 2106 I-clinical_variable
) 66 67 2106 2107 I-clinical_variable
intermediate 68 80 2108 2120 O
( 81 82 2121 2122 O
Int)-2 82 88 2122 2128 O
or 89 91 2129 2131 O
high 92 96 2132 2136 O
risk 97 101 2137 2141 O
( 102 103 2142 2143 O
i.e. 103 107 2143 2147 O
, 107 108 2147 2148 O
refractory 109 119 2149 2159 B-chronic_disease
anemia 120 126 2160 2166 I-chronic_disease
with 127 131 2167 2171 I-chronic_disease
excess 132 138 2172 2178 I-chronic_disease
blasts 139 145 2179 2185 I-chronic_disease
[ 146 147 2186 2187 I-chronic_disease
RAEB 147 151 2187 2191 I-chronic_disease
] 151 152 2191 2192 I-chronic_disease
, 152 153 2192 2193 O
RAEB 154 158 2194 2198 B-chronic_disease
in 159 161 2199 2201 I-chronic_disease
transformation 162 176 2202 2216 I-chronic_disease
[ 177 178 2217 2218 I-chronic_disease
RAEBt 178 183 2218 2223 I-chronic_disease
] 183 184 2223 2224 I-chronic_disease
) 184 185 2224 2225 O
or 186 188 2226 2228 O
refractory 189 199 2229 2239 O
anemia 200 206 2240 2246 O
with 207 211 2247 2251 O
severe 212 218 2252 2258 O
pancytopenia 219 231 2259 2271 B-chronic_disease
or 232 234 2272 2274 O
high 235 239 2275 2279 O
risk 240 244 2280 2284 O
cytogenetics 245 257 2285 2297 O

Patients 0 8 2298 2306 O
= 9 10 2307 2308 O
< 10 11 2308 2309 O
25 12 14 2310 2312 B-upper_bound
years 15 20 2313 2318 I-upper_bound

Patients 0 8 2319 2327 O
> 9 10 2328 2329 O
= 10 11 2329 2330 O
45 12 14 2331 2333 B-lower_bound
years 15 20 2334 2339 I-lower_bound

Patients 0 8 2340 2348 O
in 9 11 2349 2351 O
CR2 12 15 2352 2355 O
/ 15 16 2355 2356 O
PR2 16 19 2356 2359 O
with 20 24 2360 2364 O
initial 25 32 2365 2372 O
short 33 38 2373 2378 O
remission 39 48 2379 2388 O
( 49 50 2389 2390 O
< 50 51 2390 2391 O
6 52 53 2392 2393 B-upper_bound
months 54 60 2394 2400 I-upper_bound
) 60 61 2400 2401 O
are 62 65 2402 2405 O
eligible 66 74 2406 2414 O

Patients 0 8 2415 2423 O
in 9 11 2424 2426 O
whom 12 16 2427 2431 O
adequate 17 25 2432 2440 O
marrow 26 32 2441 2447 O
/ 32 33 2447 2448 O
biopsy 33 39 2448 2454 B-treatment
specimens 40 49 2455 2464 O
can 50 53 2465 2468 O
not 53 56 2468 2471 O
be 57 59 2472 2474 O
obtained 60 68 2475 2483 O
to 69 71 2484 2486 O
determine 72 81 2487 2496 O
remission 82 91 2497 2506 O
status 92 98 2507 2513 O
by 99 101 2514 2516 O
morphologic 102 113 2517 2528 O
assessment 114 124 2529 2539 O
, 124 125 2539 2540 O
but 126 129 2541 2544 O
have 130 134 2545 2549 O
fulfilled 135 144 2550 2559 O
criteria 145 153 2560 2568 O
of 154 156 2569 2571 O
remission 157 166 2572 2581 O
by 167 169 2582 2584 O
flow 170 174 2585 2589 B-treatment
cytometry 175 184 2590 2599 I-treatment
, 184 185 2599 2600 O
recovery 186 194 2601 2609 O
of 195 197 2610 2612 O
peripheral 198 208 2613 2623 O
blood 209 214 2624 2629 O
counts 215 221 2630 2636 O
with 222 226 2637 2641 O
no 227 229 2642 2644 O
circulating 230 241 2645 2656 O
blasts 242 248 2657 2663 O
, 248 249 2663 2664 O
and/or 250 256 2665 2671 O
normal 257 263 2672 2678 O
cytogenetics 264 276 2679 2691 O
( 277 278 2692 2693 O
if 278 280 2693 2695 O
applicable 281 291 2696 2706 O
) 291 292 2706 2707 O
may 293 296 2708 2711 O
still 297 302 2712 2717 O
be 303 305 2718 2720 O
eligible 306 314 2721 2729 O

Patients 0 8 2730 2738 O
in 9 11 2739 2741 O
whom 12 16 2742 2746 O
adequate 17 25 2747 2755 O
marrow 26 32 2756 2762 O
/ 32 33 2762 2763 O
biopsy 33 39 2763 2769 B-treatment
specimens 40 49 2770 2779 O
can 50 53 2780 2783 O
not 53 56 2783 2786 O
be 57 59 2787 2789 O
obtained 60 68 2790 2798 O
to 69 71 2799 2801 O
determine 72 81 2802 2811 O
remission 82 91 2812 2821 O
status 92 98 2822 2828 O
by 99 101 2829 2831 O
morphologic 102 113 2832 2843 O
assessment 114 124 2844 2854 O
, 124 125 2854 2855 O
but 126 129 2856 2859 O
have 130 134 2860 2864 O
fulfilled 135 144 2865 2874 O
criteria 145 153 2875 2883 O
of 154 156 2884 2886 O
remission 157 166 2887 2896 O
by 167 169 2897 2899 O
flow 170 174 2900 2904 B-treatment
cytometry 175 184 2905 2914 I-treatment
, 184 185 2914 2915 O
recovery 186 194 2916 2924 O
of 195 197 2925 2927 O
peripheral 198 208 2928 2938 O
blood 209 214 2939 2944 O
counts 215 221 2945 2951 O
with 222 226 2952 2956 O
no 227 229 2957 2959 O
circulating 230 241 2960 2971 O
blasts 242 248 2972 2978 O
, 248 249 2978 2979 O
and/or 250 256 2980 2986 O
normal 257 263 2987 2993 O
cytogenetics 264 276 2994 3006 O
( 277 278 3007 3008 O
if 278 280 3008 3010 O
applicable 281 291 3011 3021 O
) 291 292 3021 3022 O
may 293 296 3023 3026 O
still 297 302 3027 3032 O
be 303 305 3033 3035 O
eligible 306 314 3036 3044 O
; 314 315 3044 3045 O
reasonable 316 326 3046 3056 O
attempts 327 335 3057 3065 O
must 336 340 3066 3070 O
be 341 343 3071 3073 O
made 344 348 3074 3078 O
to 349 351 3079 3081 O
obtain 352 358 3082 3088 O
an 359 361 3089 3091 O
adequate 362 370 3092 3100 O
specimen 371 379 3101 3109 O
for 380 383 3110 3113 O
morphologic 384 395 3114 3125 O
assessment 396 406 3126 3136 O
, 406 407 3136 3137 O
including 408 417 3138 3147 O
possible 418 426 3148 3156 O
repeat 427 433 3157 3163 O
procedures 434 444 3164 3174 O
; 444 445 3174 3175 O
these 446 451 3176 3181 O
patients 452 460 3182 3190 O
must 461 465 3191 3195 O
be 466 468 3196 3198 O
discussed 469 478 3199 3208 O
with 479 483 3209 3213 O
the 484 487 3214 3217 O
principal 488 497 3218 3227 O
investigator 498 510 3228 3240 O
Ann 511 514 3241 3244 O
Dahlberg 515 523 3245 3253 O
prior 524 529 3254 3259 O
to 530 532 3260 3262 O
enrollment 533 543 3263 3273 O

Patients 0 8 3274 3282 O
who 9 12 3283 3286 O
have 13 17 3287 3291 O
received 18 26 3292 3300 O
Y-90 27 31 3301 3305 B-treatment
ibritumomab 32 43 3306 3317 I-treatment
( 44 45 3318 3319 I-treatment
Zevalin 45 52 3319 3326 I-treatment
) 52 53 3326 3327 I-treatment
or 54 56 3328 3330 O
I-131 57 62 3331 3336 B-treatment
tostumomab 63 73 3337 3347 I-treatment
( 74 75 3348 3349 I-treatment
Bexxar 75 81 3349 3355 I-treatment
) 81 82 3355 3356 I-treatment
, 82 83 3356 3357 O
as 84 86 3358 3360 O
part 87 91 3361 3365 O
of 92 94 3366 3368 O
their 95 100 3369 3374 O
salvage 101 108 3375 3382 B-treatment
therapy 109 116 3383 3390 I-treatment
are 117 120 3391 3394 O
not 121 124 3395 3398 O
eligible 125 133 3399 3407 O
for 134 137 3408 3411 O
Regimen 138 145 3412 3419 O
A 146 147 3420 3421 O

Patients 0 8 3422 3430 O
with 9 13 3431 3435 O
chromosome 14 24 3436 3446 B-chronic_disease
13 25 27 3447 3449 I-chronic_disease
abnormalities 28 41 3450 3463 I-chronic_disease
, 41 42 3463 3464 O
first 43 48 3465 3470 O
response 49 57 3471 3479 O
lasting 58 65 3480 3487 O
less 66 70 3488 3492 O
than 71 75 3493 3497 O
6 76 77 3498 3499 B-upper_bound
months 78 84 3500 3506 I-upper_bound
, 84 85 3506 3507 O
or 86 88 3508 3510 O
beta-2 89 95 3511 3517 B-clinical_variable
microglobulin 96 109 3518 3531 I-clinical_variable
> 110 111 3532 3533 O
3 112 113 3534 3535 B-lower_bound
mg 114 116 3536 3538 I-lower_bound
/ 116 117 3538 3539 I-lower_bound
L 117 118 3539 3540 I-lower_bound
, 118 119 3540 3541 O
may 120 123 3542 3545 O
be 124 126 3546 3548 O
considered 127 137 3549 3559 O
for 138 141 3560 3563 O
this 142 146 3564 3568 O
protocol 147 155 3569 3577 O
after 156 161 3578 3583 O
initial 162 169 3584 3591 B-treatment
therapy 170 177 3592 3599 I-treatment

Patients 0 8 3600 3608 O
with 9 13 3609 3613 O
clinical 14 22 3614 3622 O
or 23 25 3623 3625 O
laboratory 26 36 3626 3636 O
evidence 37 45 3637 3645 O
of 46 48 3646 3648 O
liver 49 54 3649 3654 B-chronic_disease
disease 55 62 3655 3662 I-chronic_disease
will 63 67 3663 3667 O
be 68 70 3668 3670 O
evaluated 71 80 3671 3680 O
for 81 84 3681 3684 O
the 85 88 3685 3688 O
cause 89 94 3689 3694 O
of 95 97 3695 3697 O
liver 98 103 3698 3703 O
disease 104 111 3704 3711 O
, 111 112 3711 3712 O
its 113 116 3713 3716 O
clinical 117 125 3717 3725 O
severity 126 134 3726 3734 O
in 135 137 3735 3737 O
terms 138 143 3738 3743 O
of 144 146 3744 3746 O
liver 147 152 3747 3752 O
function 153 161 3753 3761 O
, 161 162 3761 3762 O
histology 163 172 3763 3772 O
, 172 173 3772 3773 O
and 174 177 3774 3777 O
the 178 181 3778 3781 O
degree 182 188 3782 3788 O
of 189 191 3789 3791 O
portal 192 198 3792 3798 B-chronic_disease
hypertension 199 211 3799 3811 I-chronic_disease

Pregnant 0 8 3812 3820 B-pregnancy
or 9 11 3821 3823 O
breastfeeding 12 25 3824 3837 O

The 0 3 3838 3841 O
UCB 4 7 3842 3845 B-chronic_disease
graft 8 13 3846 3851 I-chronic_disease
is 14 16 3852 3854 O
matched 17 24 3855 3862 O
at 25 27 3863 3865 O
4 28 29 3866 3867 O
- 29 30 3867 3868 O
6 30 31 3868 3869 O
human 32 37 3870 3875 O
leukocyte 38 47 3876 3885 O
antigen 48 55 3886 3893 O
( 56 57 3894 3895 O
HLA)-A 57 63 3895 3901 O
, 63 64 3901 3902 O
B 65 66 3903 3904 O
, 66 67 3904 3905 O
DRB1 68 72 3906 3910 O
antigens 73 81 3911 3919 O
with 82 86 3920 3924 O
the 87 90 3925 3928 O
recipient 91 100 3929 3938 O
; 100 101 3938 3939 O
this 102 106 3940 3944 O
may 107 110 3945 3948 O
include 111 118 3949 3956 O
0 119 120 3957 3958 O
- 120 121 3958 3959 O
2 121 122 3959 3960 O
antigen 123 130 3961 3968 O
mismatches 131 141 3969 3979 O
at 142 144 3980 3982 O
the 145 148 3983 3986 O
A 149 150 3987 3988 O
or 151 153 3989 3991 O
B 154 155 3992 3993 O
or 156 158 3994 3996 O
DRB1 159 163 3997 4001 O
loci 164 168 4002 4006 O

UCB 0 3 4007 4010 O
units 4 9 4011 4016 O
will 10 14 4017 4021 O
be 15 17 4022 4024 O
selected 18 26 4025 4033 O
according 27 36 4034 4043 O
to 37 39 4044 4046 O
current 40 47 4047 4054 O
umbilical 48 57 4055 4064 B-treatment
cord 58 62 4065 4069 I-treatment
blood 63 68 4070 4075 I-treatment
graft 69 74 4076 4081 I-treatment
selection 75 84 4082 4091 O
algorithm 85 94 4092 4101 O

Uncontrolled 0 12 4102 4114 O
viral 13 18 4115 4120 B-chronic_disease
or 19 21 4121 4123 O
bacterial 22 31 4124 4133 B-chronic_disease
infection 32 41 4134 4143 I-chronic_disease
at 42 44 4144 4146 O
the 45 48 4147 4150 O
time 49 53 4151 4155 O
of 54 56 4156 4158 O
study 57 62 4159 4164 O
enrollment 63 73 4165 4175 O

Very 0 4 4176 4180 O
high 5 9 4181 4185 O
risk 10 14 4186 4190 O
pediatric 15 24 4191 4200 O
/ 24 25 4200 4201 O
young 25 30 4201 4206 O
adult 31 36 4207 4212 O
patients 37 45 4213 4221 O
with 46 50 4222 4226 O
acute 51 56 4227 4232 B-cancer
myeloid 57 64 4233 4240 I-cancer
leukemia 65 73 4241 4249 I-cancer
( 74 75 4250 4251 I-cancer
AML 75 78 4251 4254 I-cancer
) 78 79 4254 4255 I-cancer

atients 0 7 4256 4263 O
with 8 12 4264 4268 O
fulminant 13 22 4269 4278 B-chronic_disease
liver 23 28 4279 4284 I-chronic_disease
failure 29 36 4285 4292 I-chronic_disease
, 36 37 4292 4293 O
cirrhosis 38 47 4294 4303 B-chronic_disease
with 48 52 4304 4308 O
evidence 53 61 4309 4317 O
of 62 64 4318 4320 O
portal 65 71 4321 4327 B-chronic_disease
hypertension 72 84 4328 4340 I-chronic_disease
or 85 87 4341 4343 O
bridging 88 96 4344 4352 O
fibrosis 97 105 4353 4361 B-chronic_disease
, 105 106 4361 4362 O
alcoholic 107 116 4363 4372 B-chronic_disease
hepatitis 117 126 4373 4382 I-chronic_disease
, 126 127 4382 4383 O
esophageal 128 138 4384 4394 B-chronic_disease
varices 139 146 4395 4402 I-chronic_disease
, 146 147 4402 4403 O
a 148 149 4404 4405 O
history 150 157 4406 4413 O
of 158 160 4414 4416 O
bleeding 161 169 4417 4425 O
esophageal 170 180 4426 4436 O
varices 181 188 4437 4444 O
, 188 189 4444 4445 O
hepatic 190 197 4446 4453 B-chronic_disease
encephalopathy 198 212 4454 4468 I-chronic_disease
, 212 213 4468 4469 O
or 214 216 4470 4472 O
correctable 217 228 4473 4484 O
hepatic 229 236 4485 4492 B-chronic_disease
synthetic 237 246 4493 4502 I-chronic_disease
dysfunction 247 258 4503 4514 I-chronic_disease
evidenced 259 268 4515 4524 O
by 269 271 4525 4527 O
prolongation 272 284 4528 4540 O
of 285 287 4541 4543 O
the 288 291 4544 4547 O
prothrombin 292 303 4548 4559 B-treatment
time 304 308 4560 4564 I-treatment
, 308 309 4564 4565 O
ascites 310 317 4566 4573 B-chronic_disease
related 318 325 4574 4581 O
to 326 328 4582 4584 O
portal 329 335 4585 4591 O
hypertension 336 348 4592 4604 O
, 348 349 4604 4605 O
bacterial 350 359 4606 4615 B-chronic_disease
or 360 362 4616 4618 O
fungal 363 369 4619 4625 B-chronic_disease
abscess 370 377 4626 4633 I-chronic_disease
, 377 378 4633 4634 O
biliary 379 386 4635 4642 B-chronic_disease
obstruction 387 398 4643 4654 I-chronic_disease
, 398 399 4654 4655 O
chronic 400 407 4656 4663 B-chronic_disease
viral 408 413 4664 4669 I-chronic_disease
hepatitis 414 423 4670 4679 I-chronic_disease
with 424 428 4680 4684 O
total 429 434 4685 4690 B-clinical_variable
serum 435 440 4691 4696 I-clinical_variable
bilirubin 441 450 4697 4706 I-clinical_variable
> 451 452 4707 4708 O
3 453 454 4709 4710 B-lower_bound
mg 455 457 4711 4713 I-lower_bound
/ 457 458 4713 4714 I-lower_bound
dL 458 460 4714 4716 I-lower_bound
, 460 461 4716 4717 O
and 462 465 4718 4721 O
symptomatic 466 477 4722 4733 O
biliary 478 485 4734 4741 B-chronic_disease
disease 486 493 4742 4749 I-chronic_disease
will 494 498 4750 4754 O
be 499 501 4755 4757 O
excluded 502 510 4758 4766 O

atients 0 7 4767 4774 O
with 8 12 4775 4779 O
history 13 20 4780 4787 O
of 21 23 4788 4790 O
prior 24 29 4791 4796 B-treatment
myeloablative 30 43 4797 4810 I-treatment
transplant 44 54 4811 4821 I-treatment
containing 55 65 4822 4832 O
full 66 70 4833 4837 O
dose 71 75 4838 4842 O
TBI 76 79 4843 4846 B-treatment
( 80 81 4847 4848 O
greater 81 88 4848 4855 O
than 89 93 4856 4860 O
8 94 95 4861 4862 B-lower_bound
gray 96 100 4863 4867 O
[ 101 102 4868 4869 O
Gy 102 104 4869 4871 O
] 104 105 4871 4872 O
) 105 106 4872 4873 O
will 107 111 4874 4878 O
not 112 115 4879 4882 O
be 116 118 4883 4885 O
eligible 119 127 4886 4894 O
for 128 131 4895 4898 O
Regimen 132 139 4899 4906 O
A 140 141 4907 4908 O

blasts 0 6 4909 4915 B-clinical_variable
must 7 11 4916 4920 O
be 12 14 4921 4923 O
< 15 16 4924 4925 O
10 17 19 4926 4928 B-upper_bound
% 19 20 4928 4929 I-upper_bound
by 21 23 4930 4932 O
a 24 25 4933 4934 O
representative 26 40 4935 4949 O
bone 41 45 4950 4954 B-treatment
marrow 46 52 4955 4961 I-treatment
aspirate 53 61 4962 4970 I-treatment
morphology 62 72 4971 4981 I-treatment

comorbidity 0 11 4982 4993 B-clinical_variable
score 12 17 4994 4999 I-clinical_variable
of 18 20 5000 5002 O
5 21 22 5003 5004 B-lower_bound
or 23 25 5005 5007 O
higher 26 32 5008 5014 O

creatinine 0 10 5015 5025 B-clinical_variable
clearance 11 20 5026 5035 I-clinical_variable
> 21 22 5036 5037 O
60 23 25 5038 5040 B-lower_bound
ml 26 28 5041 5043 I-lower_bound
/ 28 29 5043 5044 I-lower_bound
min 29 32 5044 5047 I-lower_bound
( 33 34 5048 5049 O
for 34 37 5049 5052 O
children 38 46 5053 5061 O
) 46 47 5061 5062 O

ctive 0 5 5063 5068 O
or 6 8 5069 5071 O
recent 9 15 5072 5078 O
( 16 17 5079 5080 O
prior 17 22 5080 5085 B-upper_bound
6 23 24 5086 5087 I-upper_bound
month 25 30 5088 5093 I-upper_bound
) 30 31 5093 5094 O
invasive 32 40 5095 5103 O
fungal 41 47 5104 5110 B-chronic_disease
infection 48 57 5111 5120 I-chronic_disease
without 58 65 5121 5128 O
interdisciplinary 66 83 5129 5146 O
( 84 85 5147 5148 O
ID 85 87 5148 5150 O
) 87 88 5150 5151 O
consult 89 96 5152 5159 O
and 97 100 5160 5163 O
approval 101 109 5164 5172 O

flow 0 4 5173 5177 B-treatment
cytometry 5 14 5178 5187 I-treatment
in 15 17 5188 5190 O
a 18 19 5191 5192 O
representative 20 34 5193 5207 O
bone 35 39 5208 5212 O
marrow 40 46 5213 5219 O
sample 47 53 5220 5226 O
with 54 58 5227 5231 O
cellularity 59 70 5232 5243 B-clinical_variable
> 71 72 5244 5245 O
= 72 73 5245 5246 O
15 74 76 5247 5249 B-lower_bound
% 76 77 5249 5250 I-lower_bound
for 78 81 5251 5254 O
age 82 85 5255 5258 B-age

ligible 0 7 5259 5266 B-clinical_variable
with 8 12 5267 5271 I-clinical_variable
( 13 14 5272 5273 I-clinical_variable
M2 14 16 5273 5275 I-clinical_variable
marrow 17 23 5276 5282 I-clinical_variable
) 23 24 5282 5283 I-clinical_variable
with 25 29 5284 5288 O
= 30 31 5289 5290 O
< 31 32 5290 5291 O
25 33 35 5292 5294 B-upper_bound
% 35 36 5294 5295 I-upper_bound
blasts 37 43 5296 5302 I-upper_bound
in 44 46 5303 5305 O
marrow 47 53 5306 5312 O
after 54 59 5313 5318 O
having 60 66 5319 5325 O
failed 67 73 5326 5332 O
one 74 77 5333 5336 O
or 78 80 5337 5339 O
more 81 85 5340 5344 O
cycles 86 92 5345 5351 O
of 93 95 5352 5354 O
chemotherapy 96 108 5355 5367 B-treatment

one 0 3 5368 5371 O
or 4 6 5372 5374 O
2 7 8 5375 5376 O
UCB 9 12 5377 5380 B-clinical_variable
units 13 18 5381 5386 I-clinical_variable
may 19 22 5387 5390 O
be 23 25 5391 5393 O
used 26 30 5394 5398 O
to 31 33 5399 5401 O
achieve 34 41 5402 5409 O
the 42 45 5410 5413 O
required 46 54 5414 5422 O
cell 55 59 5423 5427 O
dose 60 64 5428 5432 O

patients 0 8 5433 5441 O
persistently 9 21 5442 5454 O
aplastic 22 30 5455 5463 O
for 31 34 5464 5467 O
greater 35 42 5468 5475 O
than 43 47 5476 5480 O
one 48 51 5481 5484 B-lower_bound
month 52 57 5485 5490 I-lower_bound
since 58 63 5491 5496 O
completing 64 74 5497 5507 O
last 75 79 5508 5512 O
chemotherapy 80 92 5513 5525 B-treatment
are 93 96 5526 5529 O
also 97 101 5530 5534 O
eligible 102 110 5535 5543 O
with 111 115 5544 5548 O
PI 116 118 5549 5551 O
approval 119 127 5552 5560 O

patients 0 8 5561 5569 O
who 9 12 5570 5573 O
do 13 15 5574 5576 O
not 16 19 5577 5580 O
have 20 24 5581 5585 O
high 25 29 5586 5590 O
- 29 30 5590 5591 O
risk 30 34 5591 5595 O
disease 35 42 5596 5603 O
( 43 44 5604 5605 O
high 44 48 5605 5609 O
risk 49 53 5610 5614 O
CR1 54 57 5615 5618 B-clinical_variable
, 57 58 5618 5619 O
greater 59 66 5620 5627 O
than 67 71 5628 5632 O
one 72 75 5633 5636 B-lower_bound
cycle 76 81 5637 5642 O
to 82 84 5643 5645 O
obtain 85 91 5646 5652 O
CR 92 94 5653 5655 O
or 95 97 5656 5658 O
> 98 99 5659 5660 O
= 99 100 5660 5661 O
CR2 101 104 5662 5665 B-lower_bound
) 104 105 5665 5666 O
must 106 110 5667 5671 O
be 111 113 5672 5674 O
discussed 114 123 5675 5684 O
with 124 128 5685 5689 O
the 129 132 5690 5693 O
PI 133 135 5694 5696 O
prior 136 141 5697 5702 O
to 142 144 5703 5705 O
enrollment 145 155 5706 5716 O
and 156 159 5717 5720 O
at 160 162 5721 5723 O
the 163 166 5724 5727 O
Patient 167 174 5728 5735 O
Care 175 179 5736 5740 O
Conference 180 190 5741 5751 O
or 191 193 5752 5754 O
equivalent 194 204 5755 5765 O
group 205 210 5766 5771 O
such 211 215 5772 5776 O
as 216 218 5777 5779 O
the 219 222 5780 5783 O
pediatric 223 232 5784 5793 O
leukemia 233 241 5794 5802 O
board 242 247 5803 5808 O
as 248 250 5809 5811 O
an 251 253 5812 5814 O
alternative 254 265 5815 5826 O

patients 0 8 5827 5835 O
who 9 12 5836 5839 O
do 13 15 5840 5842 O
not 16 19 5843 5846 O
have 20 24 5847 5851 O
high 25 29 5852 5856 O
- 29 30 5856 5857 O
risk 30 34 5857 5861 O
features 35 43 5862 5870 O
( 44 45 5871 5872 O
for 45 48 5872 5875 O
example 49 56 5876 5883 O
preceding 57 66 5884 5893 O
myelodysplastic 67 82 5894 5909 B-cancer
syndrome 83 91 5910 5918 I-cancer
[ 92 93 5919 5920 I-cancer
MDS 93 96 5920 5923 I-cancer
] 96 97 5923 5924 I-cancer
, 97 98 5924 5925 O
high 99 103 5926 5930 O
- 103 104 5930 5931 O
risk 104 108 5931 5935 O
cytogenetics 109 121 5936 5948 O
, 121 122 5948 5949 O
> 123 124 5950 5951 O
= 124 125 5951 5952 O
2 126 127 5953 5954 B-lower_bound
cycles 128 134 5955 5961 O
to 135 137 5962 5964 O
obtain 138 144 5965 5971 O
CR 145 147 5972 5974 O
, 147 148 5974 5975 O
erythroblastic 149 163 5976 5990 B-cancer
or 164 166 5991 5993 O
megakaryocytic 167 181 5994 6008 B-cancer
leukemia 182 190 6009 6017 I-cancer
or 191 193 6018 6020 O
> 194 195 6021 6022 O
= 195 196 6022 6023 O
CR2 197 200 6024 6027 B-lower_bound
) 200 201 6027 6028 O
must 202 206 6029 6033 O
be 207 209 6034 6036 O
discussed 210 219 6037 6046 O
with 220 224 6047 6051 O
the 225 228 6052 6055 O
principal 229 238 6056 6065 O
investigator 239 251 6066 6078 O
( 252 253 6079 6080 O
PI 253 255 6080 6082 O
) 255 256 6082 6083 O
prior 257 262 6084 6089 O
to 263 265 6090 6092 O
enrollment 266 276 6093 6103 O
and 277 280 6104 6107 O
at 281 283 6108 6110 O
the 284 287 6111 6114 O
Patient 288 295 6115 6122 O
Care 296 300 6123 6127 O
Conference 301 311 6128 6138 O
or 312 314 6139 6141 O
equivalent 315 325 6142 6152 O
group 326 331 6153 6158 O
such 332 336 6159 6163 O
as 337 339 6164 6166 O
the 340 343 6167 6170 O
pediatric 344 353 6171 6180 B-cancer
leukemia 354 362 6181 6189 I-cancer
board 363 368 6190 6195 O
as 369 371 6196 6198 O
an 372 374 6199 6201 O
alternative 375 386 6202 6213 O

patients 0 8 6214 6222 O
with 9 13 6223 6227 O
bulky 14 19 6228 6233 B-chronic_disease
disease 20 27 6234 6241 I-chronic_disease
( 28 29 6242 6243 O
nodal 29 34 6243 6248 B-clinical_variable
mass 35 39 6249 6253 I-clinical_variable
greater 40 47 6254 6261 O
than 48 52 6262 6266 O
5 53 54 6267 6268 B-lower_bound
cm 55 57 6269 6271 I-lower_bound
) 57 58 6271 6272 O
should 59 65 6273 6279 O
be 66 68 6280 6282 O
considered 69 79 6283 6293 O
for 80 83 6294 6297 O
debulking 84 93 6298 6307 B-treatment
chemotherapy 94 106 6308 6320 I-treatment
before 107 113 6321 6327 O
transplant 114 124 6328 6338 B-treatment

stage 0 5 6339 6344 B-lower_bound
III 6 9 6345 6348 I-lower_bound
/ 9 10 6348 6349 O
IV 10 12 6349 6351 B-upper_bound
patients 13 21 6352 6360 O
are 22 25 6361 6364 O
eligible 26 34 6365 6373 O
after 35 40 6374 6379 O
progression 41 52 6380 6391 O
in 53 55 6392 6394 O
CR 56 58 6395 6397 O
/ 58 59 6397 6398 O
PR 59 61 6398 6400 O

these 0 5 6401 6406 O
patients 6 14 6407 6415 O
must 15 19 6416 6420 O
be 20 22 6421 6423 O
discussed 23 32 6424 6433 O
with 33 37 6434 6438 O
the 38 41 6439 6442 O
PI 42 44 6443 6445 O
prior 45 50 6446 6451 O
to 51 53 6452 6454 O
enrollment 54 64 6455 6465 O
; 64 65 6465 6466 O
patients 66 74 6467 6475 O
persistently 75 87 6476 6488 O
aplastic 88 96 6489 6497 O
for 97 100 6498 6501 O
greater 101 108 6502 6509 O
than 109 113 6510 6514 O
one 114 117 6515 6518 B-lower_bound
month 118 123 6519 6524 I-lower_bound
since 124 129 6525 6530 O
completing 130 140 6531 6541 O
last 141 145 6542 6546 B-treatment
chemotherapy 146 158 6547 6559 I-treatment
are 159 162 6560 6563 O
also 163 167 6564 6568 O
eligible 168 176 6569 6577 O
with 177 181 6578 6582 O
PI 182 184 6583 6585 O
approval 185 193 6586 6594 O

to 0 2 6595 6597 O
be 3 5 6598 6600 O
eligible 6 14 6601 6609 O
in 15 17 6610 6612 O
first 18 23 6613 6618 O
chronic 24 31 6619 6626 O
phase 32 37 6627 6632 O
( 38 39 6633 6634 O
CP1 39 42 6634 6637 O
) 42 43 6637 6638 O
patient 44 51 6639 6646 O
must 52 56 6647 6651 O
have 57 61 6652 6656 O
failed 62 68 6657 6663 O
or 69 71 6664 6666 O
be 72 74 6667 6669 O
intolerant 75 85 6670 6680 O
to 86 88 6681 6683 O
imatinib 89 97 6684 6692 B-treatment
mesylate 98 106 6693 6701 I-treatment

